New research, funded by Diabetes UK, has found that use of an artificial pancreas by woman suffering from type 1 diabetes during pregnancy may drastically reduce cases of stillbirth and mortality rates...
Category: Science
New findings by researchers at UT Southwestern Medical Center may hold a cure for type 1 diabetes.
According to the findings, type 1 diabetes could be converted to an asymptomatic, non-insulin-dependent disorder by eliminating the actions of a specific hormone...
The University of California, San Francisco (UCSF) and sanofi-aventis have formed two new research and development collaborations that join together leaders from academia and industry to more rapidly advance groundbreaking innovation from the lab to the patient. The first collaboration promotes innovative research in pharmacological science and in multiple therapeutic areas, such as oncology, aging, diabetes and inflammation...
"Our work found that naringenin, the flavonoid responsible for the bitter taste in grapefruit, could have a strong insulin sensitizing and lipid lowering effect..."
We have shown that beta cells from adult human islets can be made to multiply in tissue culture, but during this process they lose their ability to produce insulin...
Sanofi-aventis announced it has signed a global licensing and patent transfer agreement with Ascendis Pharma (Ascendis) on Ascendis’ proprietary TransCon Linker and Hydrogel carrier technology, which allows for a drug compound to be released in the body in a precise, time-controlled fashion, creating a long-acting effect...
Living Cell Technologies announced that its Russian subsidiary, LCT Biomedical Limited, has received registration of the company’s groundbreaking diabetes treatment, DIABECELL, as a marketable medical technology in Russia. Registration allows for the sale and use of the DIABECELL technology in the treatment of type 1 diabetes in Russia....
Human spermatogonial stem cells extracted from testicular tissue can be turned into insulin-secreting beta islet cells normally found in the pancreas, say scientists from Georgetown University Medical Center (GUMC)...
Medical scientists at the University of Leicester have identified for the first time a new way in which the body controls blood sugar levels following a meal.
The researchers discovered that in order to maintain the correct levels of sugar, a protein present on the cells that release insulin in the pancreas has to be active. This protein, called the M3-muscarinic receptor...
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. have agreed to to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes which will be conducted at The University of Texas (UT) Southwestern Medical Center...